19 June 2025
Sycomore Corporate Finance has advised Five Arrows in the context of its exclusive negotiations for a strategic investment in Hublo alongside its founding and leadership team and Revaia, who reinvest in the new transaction.
Hublo, a leading provider of digital HR solutions for the healthcare sector, announces a major milestone in its development with a strategic investment from Five Arrows, through its lower mid-market growth strategy. This strategy is part of the “Tibi Initiative” sponsored by the French Presidency, a programme which aims to promote investment in the most innovative technology companies in France and Europe.
Since its founding in 2016, Hublo has been on a mission to transform the daily lives of healthcare professionals by modernising the way human resources are managed. Its innovative software suite enables healthcare organisations to recruit, manage, and retain their teams more effectively, allowing staff to focus on what matters most – patient care. Today, Hublo’s solutions are used by over 5,000 healthcare and social care institutions and more than one million caregivers across France.
In a healthcare software market that remains highly fragmented, Hublo is positioning itself as the leading provider of a unified digital platform dedicated to workforce management.
To achieve this ambition, the company is pursuing a strategy focused on continuous innovation, the expansion of its product offering, and the development of strategic partnerships – most recently demonstrated through the acquisitions of Permuteo and Staffea in April 2025.
The investment from Five Arrows will support Hublo, alongside its founding and leadership team,
in accelerating their growth journey – both organically and through acquisitions – in France and internationally. With deep experience in scaling healthcare technology platforms, Five Arrows will bring long-term strategic and operational support to the company.
Revaia, Hublo’s anchor shareholder since 2021, will sell its stake held through the Revaia Growth
I fund as part of the transaction. As a testament to its continued confidence in Hublo and its leadership team, Revaia is considering a significant reinvestment alongside Five Arrows, reaffirming its commitment to supporting the company in the next phase of its journey.
Antoine Loron, co-founder and co-CEO of Hublo:
“The entry of Five Arrows marks a significant step in our growth. With their support, we are well positioned to deliver on our vision – both in France and abroad – to service the healthcare system. A new chapter begins.”
Adrien Beata, co-founder and co-CEO of Hublo:
“The trust placed in us by a leading technology investor such as Five Arrows, and the renewed support of Revaia, confirms that we are on the right path. Hublo delivers real value to healthcare institutions, improves working conditions for caregivers, and ultimately helps enhance the quality of care.”
Jean-Daniel Bertoncini, partner at Five Arrows:
“Hublo stands out as the leading next generation platform for talent management in healthcare. We have been impressed by the team’s vision, execution, and commitment to creating solutions that make life easier for caregivers and healthcare institutions alike so they can focus on delivering quality care when it is needed. We look forward to working closely with the founders and management team to support Hublo in this next phase of growth.”
Alice Albizzati, founding partner at Revaia:
“Hublo exemplifies the type of mission-driven European tech company we are proud to back. Since our first investment in 2021, the team has built a robust and scalable platform with a real impact on society.”
The completion of the transaction is expected to take place in the coming weeks and is subject to customary closing conditions.
In the context of this Transaction, Sycomore Corporate Finance acted as Financial Advisor to Five Arrows. The transaction team comprised Tristan Dupont, Malo Grosso and Arthur Neron.